New gene-altering treatment offered for certain blood cancers
Siteman Cancer Center and Washington University is one of the first centers nationwide to offer CAR-T cell therapy that targets certain blood cancers. Newly FDA approved for types of advanced non-Hodgkin lymphoma in adults, the therapy uses a patient’s own immune system to fight cancer. October 20, 2017